Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles: Therapeutics, Targets, and Development

Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin

Andrea Newbold, Ralph K. Lindemann, Leonie A. Cluse, Kate F. Whitecross, Anthony E. Dear and Ricky W. Johnstone
Andrea Newbold
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph K. Lindemann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonie A. Cluse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate F. Whitecross
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony E. Dear
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricky W. Johnstone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-07-2256 Published May 2008
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: May 2008 to March 2021

AbstractFull-text HTMLPDF
Total210938891710

Cited By

Article Information

Volume 7, Issue 5, pp. 1066-1079

DOI 
https://doi.org/10.1158/1535-7163.MCT-07-2256
PubMed 
18483296

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • February 21, 2008
  • November 4, 2007
  • February 5, 2008
  • Published first May 15, 2008.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Andrea Newbold1,
  2. Ralph K. Lindemann12,
  3. Leonie A. Cluse1,
  4. Kate F. Whitecross1,
  5. Anthony E. Dear3 and
  6. Ricky W. Johnstone14
  1. 1Cancer Immunology Program, Peter MacCallum Cancer Centre, Trescowthick Research Laboratories, East Melbourne, Victoria, Australia; 2National Center for Tumor Diseases/German Cancer Research Center, Department of Translational Oncology G100, Heidelberg, Germany; 3Australian Centre for Blood Diseases, Monash University, Prahran, Melbourne, Victoria, Australia; and 4University of Melbourne, Parkville, Victoria, Australia
  1. Requests for reprints: Ricky W. Johnstone, Cancer Immunology Program, Peter MacCallum Cancer Centre, Trescowthick Research Laboratories, St. Andrews Place, East Melbourne, Victoria 3002, Australia. Phone: 61-3-9656-3727; Fax: 61-3-9656-1411. E-mail: ricky.johnstone{at}petermac.org
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 7 (5)
May 2008
Volume 7, Issue 5
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin
Andrea Newbold, Ralph K. Lindemann, Leonie A. Cluse, Kate F. Whitecross, Anthony E. Dear and Ricky W. Johnstone
Mol Cancer Ther May 1 2008 (7) (5) 1066-1079; DOI: 10.1158/1535-7163.MCT-07-2256

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin
Andrea Newbold, Ralph K. Lindemann, Leonie A. Cluse, Kate F. Whitecross, Anthony E. Dear and Ricky W. Johnstone
Mol Cancer Ther May 1 2008 (7) (5) 1066-1079; DOI: 10.1158/1535-7163.MCT-07-2256
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
  • Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors
  • WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells
Show more Research Articles: Therapeutics, Targets, and Development
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement